← MESA LABORATORIES INC /CO/ MLAB
Market Price
$106.14
Market Cap
$621.66M
P/E Ratio
87.72
Revenue (FY 2026)
↑3.4% YoY
$249.13M
3-Yr CAGR: 4.4%
Net Income
↑440.0% YoY
$6.71M
Net Margin: 2.7%
Free Cash Flow
↓-7.0% YoY
$39.58M
FCF Yield: 6.37%
EPS (Diluted)
↑436.1% YoY
$1.21
Basic: $1.22
Return on Equity
Efficiency
3.6%
ROA: 75.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MLAB)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $93.7M | — | $53.2M | $11.2M | — | $2.91 | — | $7.8M | $-3.9M | — |
| FY 2018 | $96.2M | +2.7% | $54.6M | $-3.0M | -126.5% | $-0.79 | -127.1% | $24.8M | $22.0M | +671.1% |
| FY 2019 | $103.1M | +7.2% | $60.9M | $7.5M | +352.7% | $1.86 | +335.4% | $30.6M | $29.3M | +33.1% |
| FY 2020 | $117.7M | +14.1% | $64.9M | $1.3M | -82.0% | $0.31 | -83.3% | $26.6M | $25.1M | -14.4% |
| FY 2021 | $133.9M | +13.8% | $87.0M | $3.3M | +142.7% | $0.64 | +106.5% | $37.1M | $35.1M | +40.0% |
| FY 2022 | $184.3M | +37.6% | $109.1M | $1.9M | -42.9% | $0.35 | -45.3% | $39.2M | $34.8M | -0.8% |
| FY 2023 | $219.1M | +18.8% | $133.7M | $0.9M | -50.3% | $0.17 | -51.4% | $28.0M | $23.4M | -32.6% |
| FY 2024 | $216.2M | -1.3% | $133.2M | $-254.2M | -27,438.3% | $-47.20 | -27,864.7% | $44.1M | $41.6M | +77.3% |
| FY 2025 | $241.0M | +11.5% | $150.9M | $-2.0M | +99.2% | $-0.36 | +99.2% | $46.8M | $42.6M | +2.4% |
| FY 2026 | $249.1M | +3.4% | $158.3M | $6.7M | +440.0% | $1.21 | +436.1% | $42.8M | $39.6M | -7.0% |
Valuation
Market Price
$106.14
Market Cap
$621.66M
Enterprise Value
$662.23M
P/E Ratio
87.72
P/B Ratio
3.15
FCF Yield
6.37%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
63.53%
Operating Margin
7.43%
Net Margin
2.69%
Return on Equity (ROE)
3.60%
Return on Assets (ROA)
75.69%
Asset Turnover
28.09x
Revenue 3-Yr CAGR
4.38%
Financial Health & Liquidity
Current Ratio
0.50
Cash Ratio
1.53
Debt / Equity
0.362
Debt / Assets
7.612
Cash & Equivalents
$26.93M
Total Debt
$67.50M
Book Value / Share
$33.71
Cash Flow Efficiency
Operating Cash Flow
$42.83M
Capital Expenditures (CapEx)
$3.25M
Free Cash Flow
$39.58M
OCF / Revenue
17.19%
FCF / Revenue
15.89%
FCF 3-Yr CAGR
19.08%
Per Share Metrics
EPS (Diluted)
$1.21
EPS (Basic)
$1.22
Dividends / Share
N/A
Book Value / Share
$33.71
EPS YoY Growth
436.11%
Balance Sheet (FY 2026)
Total Assets
$8.87M
Total Liabilities
$17.62M
Stockholders' Equity
$186.25M
Current Assets
$8.87M
Current Liabilities
$17.62M